Results 131 to 140 of about 21,646 (232)

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile

Cost Effectiveness and Resource Allocation
Background Atrial fibrillation (AF) is the most common sustained arrhythmia in adults, associated with significant morbidity, mortality, and economic burden due to thromboembolic events.
Tomás Abbot, Nicolás Armijo, Luis Rojas Orellana, Andrés Giglio Jiménez, Carlos Balmaceda, Manuel Espinoza   +5 more
doaj   +1 more source

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

, 2012
Ola E Dahl1,21Department of Orthopaedics, Innlandet Hospital Trust, Elverum Central Hospital, Elverum, Norway; 2Thrombosis Research Institute, London, UKAbstract: Venous thromboembolism, presenting as deep vein thrombosis or pulmonary embolism, is a ...
Dahl OE
core  

Anticoagulation With Dabigatran: When to Worry

, 2015
Dabigatran etexilate is the prodrug of dabigatran, a direct thrombin inhibitor that is used to reduce the risk for stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF) and to prevent and treat venous thromboembolism (VTE)
Singh-Franco, Devada
core  

Idarucizumab, il nuovo antidoto all'anticoagulante Dabigatran

, 2019
Dabigatran appartiene ad una nuova generazione di anticoagulanti orali approvati nel corso degli ultimi anni che offrono a medici e pazienti una più vasta gamma di opzioni per curare malattie tromboemboliche e per prevenire l’ictus nei pazienti con ...
HOLOVACH, VASYLYNA
core  

Modulatory Effects of Dabigatran on PAR-1 Activity and Viability in Adipose-Derived Mesenchymal Stem Cells. [PDF]

Int J Mol Sci
Kubat E, Gürpınar ÖA, Özdem T.
europepmc   +1 more source

A Review of Dabigatran, an Oral Anticoagulant

, 2019
Serious clinical complications associated with venous thrombotic embolism (VTE) necessitate prophylaxis in patient groups who are at high risk of VTE, specifically those recovering from orthopedic surgery with atrial fibrillation, with mechanical heart ...
Hallman, Lindsey A., Carey, Rebecca A., Spicer, James, Rounds, Chad A., Hume, Nicole R., Kier, Karen L.   +5 more
core  

Warfarin versus Dabigatran: the Superior Option

, 2016
Background: Atrial fibrillation (AF) is an arrhythmia that increases the risks of blood clots, stroke, heart failure. Oral antithrombotic and anticoagulation have been associated with the reduced formation of thrombus thus reducing the risk of AF-related
El Balaa, Aya, Castonguay, Krista
core  

Trend of Reported Bleeding in Warfarin Compared with Direct Oral Anticoagulants in Japan. [PDF]

Drug Healthc Patient Saf
Takami A, Terashima G, Tajima T, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source